Ancilia Biosciences Selected to Receive $3 Million Award from ARPA-H’s Sprint for Women’s Health Ancilia has been awarded $3M from the prestigious ARPA-H Sprint for Women’s Health to develop a novel therapy for bacterial vaginosis through IND filing.